Cardiol Therapeutics (CRDL) Enterprise Value (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Enterprise Value came in at -$20.2 million in Q1 2026, down 24.31% YoY from -$26.7 million in Q1 2025, and down 31.4% on a QoQ basis from -$15.4 million in Q4 2025.
Cardiol Therapeutics (CRDL) Enterprise Value (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Enterprise Value data on file, last reported at -$20.2 million in Q1 2026.
- Quarterly Enterprise Value fell 24.31% year-over-year to -$20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.2 million (down 24.31% YoY) and the FY2025 annual result came in at -$15.4 million, up 29.84% from the prior year.
- Enterprise Value slipped to -$20.2 million in Q1 2026, from -$15.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$8.4 million in Q3 2025 to a low of -$59.1 million in Q1 2022.
- A 5-year average of -$28.2 million and a median of -$21.9 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value tumbled 120.75% — and 2024, when it surged 61.49%.
- Tracing CRDL's Enterprise Value over 5 years: stood at -$43.8 million in 2022, then soared by 41.43% to -$25.7 million in 2023, then gained by 14.68% to -$21.9 million in 2024, then gained by 29.84% to -$15.4 million in 2025, then tumbled by 31.4% to -$20.2 million in 2026.
- The last three Enterprise Value figures came in at -$20.2 million (Q1 2026), -$15.4 million (Q4 2025), and -$8.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | -18.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.18 Mn |
| Dec 31, 2025 | -15.36 Mn |
| Sep 30, 2025 | -8.45 Mn |
| Jun 30, 2025 | -13.13 Mn |
| Mar 31, 2025 | -16.23 Mn |
| Dec 31, 2024 | -21.89 Mn |
| Sep 30, 2024 | -11.64 Mn |
| Jun 30, 2024 | -17.56 Mn |
| Mar 31, 2024 | -21.20 Mn |
| Dec 31, 2023 | -25.66 Mn |
| Sep 30, 2023 | -30.24 Mn |
| Jun 30, 2023 | -33.46 Mn |
| Mar 31, 2023 | -36.59 Mn |
| Dec 31, 2022 | -43.81 Mn |
| Sep 30, 2022 | -50.25 Mn |
| Jun 30, 2022 | -55.26 Mn |
| Mar 31, 2022 | -59.09 Mn |
| Dec 31, 2021 | -66.56 Mn |
| Sep 30, 2021 | -22.76 Mn |
| Jun 30, 2021 | -26.62 Mn |